ZTS Zoetis Inc
Company Analysis
Latest News
🔴 Zoetis drops 4.04% after Q3 earnings reveal U.S. companion-animal revenue decline
Zoetis is trading 4.04% down at $78.79 on November 6, following its Q3 2026 earnings report released yesterday. - Third-quarter revenue fell 1% year over year...
🔴 Zoetis is trading 5% down today as S&P 500 and Nasdaq slide
Zoetis is trading 5.21% down at $84.30 on November 5 amid a broader-market sell-off. - The S&P 500 is down 3.16% and Nasdaq is down 4.86%; broad risk-off...
Zoetis' third quarter 2026 revenue of $2.4B and EPS beat analyst estimates
Zoetis reported third quarter 2026 results that exceeded expectations on both the top and bottom lines, despite continued headwinds in the U.S. pet market....
🟢 Zoetis is trading 5% up today amid a broad market rally
Zoetis is trading at $87.08, up 4.80%, with a broad market rally the likeliest context for the move, though reporting has not directly linked the gains to...
Zoetis Inc Q3 2026 Earnings Preview: What Analysts Expect on November 05, 2026
Zoetis is projected to report Q3 2026 revenue of $2.30 billion and adjusted EPS of $1.51, with the stock currently trading near $82.24 against a consensus...
🟢 Zoetis is trading 4.11% up — no confirmed catalyst
Zoetis is trading at $83.00, up +4.11%, with no clearly confirmed catalyst directly explaining the November 2 move. - Coverage highlighted FDA approval of...
Zoetis Downgraded as Jefferies Cuts Target to $83 on Pricing Risks
Jefferies downgraded Zoetis (NYSE: ZTS) from Buy to Hold and cut its price target from $103 to $83. Shares fell in pre-market trading. The firm cited concerns...
🔴 Zoetis is trading 12.05% down in after-hours trading; cause unclear
Zoetis is trading 12.05% down at $70.00 after-hours; the cause of the October 19 decline remains unclear, with no verified company-specific announcement...
🟢 Zoetis is trading 4.2% up today as investors favor healthcare amid inflation concerns
Zoetis is trading at $78.44, up 4.19%, as healthcare shares gain in a defensive rotation. - Investors are responding to hotter-than-expected inflation data and...
🔴 Zoetis is trading 6.8% down in after-hours trading with no confirmed cause
Zoetis is trading 6.8% down at $69.27 after hours, with the cause unclear. - No confirmed company-specific announcement explains the move; the October 13 board...
Zoetis Hits 52-Week Low Amid Analyst Price Target Cuts
Zoetis (ZTS) shares hit a new 52-week low on September 21, 2026. The stock traded as low as $70.54. The decline follows cautious analyst updates amid a...
🔴 Zoetis is trading 5.64% down in after-hours trading amid softer companion-animal demand and tougher competition
Zoetis is trading at $69.27 (-5.64%) after management highlighted softer companion-animal demand and tougher competition. - At the September 14 Morgan Stanley...
Value Investor Tweedy Browne Takes New $40M Stake in Zoetis (ZTS)
Following the value-oriented investment philosophy of Benjamin Graham, Tweedy Browne established a new position in Zoetis, the world's largest producer of...
David Rolfe's Wedgewood Partners exits its entire Zoetis (ZTS) position
In a recent 13F filing, David Rolfe's Wedgewood Partners revealed it had sold its entire stake in animal health company Zoetis. The filing, which reflects...
🟢 Zoetis is trading 4% up today on a healthcare-sector rally
Zoetis is trading 4.01% up at $78.03, with the gain aligned with healthcare-sector strength. - XLV is up 1.29%, alongside modestly positive major indexes and...
Polen Capital Slashes Zoetis Stake by 92%
In a significant portfolio shift, Polen Capital Management reduced its holding in animal health company Zoetis by 92.41% during the second quarter of 2026....
🟢 Zoetis is trading 4.07% up today as healthcare stocks rally
Zoetis is trading 4.07% up now at $77.31 as healthcare stocks rally. - Healthcare gains reflect improving earnings expectations, attractive valuations,...
Tweedy Browne's Q2 13F: New Stake in Zoetis, Exits Sealed Air, Trims FedEx
In its second-quarter 13F filing, Tweedy Browne revealed a portfolio valued at $1.32 billion, a slight increase from the previous quarter. The firm, known for...
Terry Smith's Fundsmith exits $458M stake in animal health giant Zoetis
Terry Smith's Fundsmith has completely sold its position in Zoetis (ZTS), the world's largest producer of medicine and vaccinations for pets and livestock. An...
🔴 Zoetis is trading 6.4% down in after-hours trading amid broader market sell-off
Zoetis is trading 6.4% down at $69.27 after the broader market sold off on August 18, 2026. - Technology-led weakness, rising Treasury yields, higher oil...